Concepedia

Elliasu Y. Salifu

EY

8

Publications

137

Citations

8

H-Index

2019

Active since

Affiliations

University of KwaZulu-Natal(Current)

Elliasu Y. Salifu is an author at University of KwaZulu-Natal specializing in drug discovery, small molecules, and tumor biology.

ORCID

Top concepts

Publications per year

2019–2024

8

Publications

8

Discovery of Potential KRAS‐SOS1 Inhibitors from South African Natural Compounds: An <i>In silico</i> Approach

Abdul Rashid Issahaku, Elliasu Y. Salifu, Clement Agoni et al. · ChemistrySelect · 2023 · 50 citations · Full text

, , +22

CF<sub>3</sub>‐Pyridinyl Substitution on Antimalarial Therapeutics: Probing Differential Ligand Binding and Dynamical Inhibitory Effects of a Novel Triazolopyrimidine‐Based Inhibitor on <i>Plasmodium falciparum</i> Dihydroorotate Dehydrogenase

Clement Agoni, Elliasu Y. Salifu, Geraldene Munsamy et al. · Chemistry & Biodiversity · 2019 · 18 citations

Highlighting the mechanistic role of Olutasidenib (FT-2102) in the selective inhibition of mutated isocitrate dehydrogenase 1 (mIDH1) in cancer therapy

Elliasu Y. Salifu, Clement Agoni, Mahmoud E. S. Soliman · Informatics in Medicine Unlocked · 2021 · 14 citations · Full text

Evaluating the Therapeutic Potential of Curcumin and Synthetic Derivatives: A Computational Approach to Anti-Obesity Treatments

Marakiya T. Moetlediwa, Babalwa Jack, Sithandiwe E. Mazibuko-Mbeje et al. · International Journal of Molecular Sciences · 2024 · 13 citations · Full text

Halting ionic shuttle to disrupt the synthetic machinery—Structural and molecular insights into the inhibitory roles of Bedaquiline towards <i>Mycobacterium tuberculosis</i> ATP synthase in the treatment of tuberculosis

Elliasu Y. Salifu, Clement Agoni, Fisayo A. Olotu et al. · Journal of Cellular Biochemistry · 2019 · 12 citations

Rows per page

1–5 of 8